Since reduced ACE2 expression implies increased Ang II availability, COVID-19 patients with pre-existing hypertension may experience large blood pressure (BP) fluctuations, making them especially susceptible to hemorrhagic stroke episodes. The gene discussed is ACE2; the disease is hemorrhagic stroke.